These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2680009)

  • 1. Progress report on the Canadian Multicentre Trial of tetrahydroaminoacridine with lecithin in Alzheimer's disease.
    Gauthier S; Bouchard R; Bacher Y; Bailey P; Bergman H; Carrier L; Charbonneau R; Clarfield M; Collier B; Dastoor D
    Can J Neurol Sci; 1989 Nov; 16(4 Suppl):543-6. PubMed ID: 2680009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
    Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C
    Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood.
    Vida S; Gauthier L; Gauthier S
    Can J Psychiatry; 1989 Apr; 34(3):165-70. PubMed ID: 2655861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease and THA: a review of the cholinergic theory and of preliminary results.
    Boller F; Forette F
    Biomed Pharmacother; 1989; 43(7):487-91. PubMed ID: 2684292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydroaminoacridine and lecithin for Alzheimer's disease.
    N Engl J Med; 1990 Sep; 323(13):919-20. PubMed ID: 2395447
    [No Abstract]   [Full Text] [Related]  

  • 8. An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease. The Tacrine 970-6 Study Group.
    Foster NL; Petersen RC; Gracon SI; Lewis K
    Dementia; 1996; 7(5):260-6. PubMed ID: 8872417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrine in Alzheimer's disease.
    Eagger SA; Levy R; Sahakian BJ
    Lancet; 1991 Apr; 337(8748):989-92. PubMed ID: 1673209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent Alzheimer's disease.
    Kumar V; Becker RE
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):478-85. PubMed ID: 2684868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydroaminoacridine (THA) in Alzheimer's disease.
    Byrne J; Arie T
    BMJ; 1989 Apr; 298(6677):845-6. PubMed ID: 2497817
    [No Abstract]   [Full Text] [Related]  

  • 12. Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease. Effect on cognition, functioning in daily life, behavioural disturbances and burden experienced by the carers.
    Weinstein HC; Teunisse S; van Gool WA
    J Neurol; 1991 Feb; 238(1):34-8. PubMed ID: 2030370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease.
    Perryman KM; Fitten LJ
    Life Sci; 1993; 53(6):479-86. PubMed ID: 8341134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin.
    Cohen MB; Fitten LJ; Lake RR; Perryman KM; Graham LS; Sevrin R
    Clin Nucl Med; 1992 Apr; 17(4):312-5. PubMed ID: 1572123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.
    Maltby N; Broe GA; Creasey H; Jorm AF; Christensen H; Brooks WS
    BMJ; 1994 Apr; 308(6933):879-83. PubMed ID: 8173365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrine in Alzheimer's disease.
    Davies B; Andrewes D; Stargatt R; Ames D; Tuckwell V; Davis S
    Lancet; 1989 Jul; 2(8655):163-4. PubMed ID: 2567933
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of tacrine and lecithin in Alzheimer's disease. A population pharmacodynamic analysis of five clinical trials.
    Holford NH; Peace K
    Eur J Clin Pharmacol; 1994; 47(1):17-23. PubMed ID: 7988619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydroaminoacridine and Alzheimer's disease.
    Lancet; 1987 Feb; 1(8530):444-5. PubMed ID: 2880235
    [No Abstract]   [Full Text] [Related]  

  • 20. Tetrahydroaminoacridine and Alzheimer's disease.
    Levy R
    Lancet; 1987 Feb; 1(8528):322. PubMed ID: 2880126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.